ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2640

Performance of Berden’s Classification and ANCA Renal Risk Score for the Prediction of End-Stage Renal Disease in ANCA-associated Vasculitis

Onay Gercik1, Emre Bilgin 2, Dilek Solmaz 1, Fulya Cakalagaoglu 3, Arzu Saglam 4, Ozge Aybi 5, Riza Kardas 5, Zeki Soypacaci 6, Gokhan Kabadayi 7, Tolga Yildirim 8, İdil Kurut Aysin 9, Omer Karadag 10 and Servet Akar 11, 1Izmir Katip Celebi University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, İzmir, Turkey, 2Hacettepe University Vasculitis Centre, Ankara, Turkey, Ankara, Turkey, 3Izmir Katip Celebi University, Faculty of Medicine, Department of Pathology, Izmir, Turkey, 4Hacettepe University, Faculty of Medicine, Department of Pathology, Ankara, Turkey, 5Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Ankara, Turkey, 6Izmir Katip Celebi University Faculty of Medicine, Department of Internal Medicine, Division of Nephrology, Izmir, Turkey, 7Izmir Katip Celebi University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, İzmir, Turkey, 8Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Nephrology, Ankara, Turkey, 9Izmir Katip Celebi University Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, İzmir, Turkey, 10Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey, 11Izmir Katip Celebi University, Faculty of Medicine, Division of Rheumatology, İzmir, Turkey

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: ANCA and histopathologic, systemic vasculitides

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: Vasculitis – ANCA-Associated Poster I

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Renal involvement in ANCA-associated vasculitides (AAVs) is an important factor for morbidity and mortality. Berden’s histopathologic classification for ANCA-associated glomerulonephritis has been proven to be helpful for predicting the renal outcome. Recently, the ANCA renal risk score, a new scoring system which needs to be validated, has been proposed to predict end-stage renal disease (ESRD) in AAV patients. In this study, we aimed a) to assess prognostic factors for renal survival in our AAV patients with renal involvement, b) to evaluate the performances of the Berden’s histopathological classification and ANCA-renal risk score, for predicting ESRD.

Methods: Patients with AAV who were categorized according to the 2012 Chapel Hill consensus nomenclature were included in this study. Patients with only renal involvement clinically and diagnosed by renal biopsy were classified as renal-limited vasculitis (RLV). Renal biopsies were reviewed according to the Berden’s histopathological classification, and the percentages of normal glomeruli, tubular atrophy and interstitial fibrosis were determined in order to calculate ANCA renal risk score. The clinical data and laboratory parameters were collected retrospectively. Renal survival was defined as the time between diagnosis and the development of ESRD. Factors predictive of renal survival were evaluated by Kaplan-Meier method and the Cox proportional hazard model.

Results: 167 AAV patients with renal involvement were included in the study. ESRD had developed in 52 (34%) patients and renal survival was median 31 (0-240) months. According to the histopathological classification ESRD had developed in %79 patients in the sclerotic group, % 51 patients in the crescentic group, %32 patients in the mixed group and %18 patients in focal group (p=0.003). According to the ANCA renal risk score, ESRD had developed in %8 patients in the low-risk group, %42 patients in the medium-risk group and %67 patients in the high-risk group (p=0.005). In univariate analysis the age at diagnosis (HR 1.02, 95 % CI 1.00-1.04, p=0.045), AAV subgroups (p=0.01) (Figure), histopathological classification (p=0.009), ANCA renal risk score (p=0.01), maximum creatinine level at diagnosis  (HR 1.14, 95 % CI 1.09-1.19, p< 0.001), glomerular filtration rate (GFR) (HR 0.92, 95 % CI 0.89-0.95, p< 0.001), hemodialysis (HR 4.81, 95 % CI 2.53-9.17, p< 0.001) and plasmapheresis at diagnosis (HR 2.36, 95 % CI 1.32-4.22, p=0.004) were the factors associated with renal survival. In multivariate analysis, histopathological classification predicted mortality in model 1, but when GFR at diagnosis is included in the model (model 2), the model lost its significance.  However, the ANCA renal risk score was found to be an independent prognostic risk factor for renal survival (model 3, table 2).

Conclusion: According to our results, the ANCA renal risk score may be more advantageous in predicting ESRD development compared to Berden’s histopathological classification, and this may be due to the inclusion of glomerular filtration in scoring.


table1_renal_survival

Table 1. Demographic, clinical characteristics, histopathological classes and ANCA-renal risk scores of ANCA-associated vasculitis patients with renal involvement


table2_renal_survival

Table 2. Multivariate analysis models which predict renal survival in ANCA-associated vasculitis


figure_renal_survival

Figure. The results of the Kaplan-Meier analysis. Renal survival was significantly associated with AAV subgroups patients with ANCA-associated vasculitis with renal involvement

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/performance-of-berdens-classification-and-anca-renal-risk-score-for-the-prediction-of-end-stage-renal-disease-in-anca-associated-vasculitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology